IDH1 and central nervous system cancer: In both low- and high-grade gliomas with IDH mutations, combined loss of the short arm of chromosome 1 (1p) and the long arm of chromosome 19 (19q; 1p/19q co-deletion) is prognostic of a more favorable outcome than equivalent tumors without this co-deletion (13–15).